Followers | 39 |
Posts | 3017 |
Boards Moderated | 0 |
Alias Born | 07/29/2006 |
Saturday, July 30, 2016 8:49:31 PM
Recent MCRB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2024 10:33:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2024 10:27:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2024 10:24:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2024 10:23:01 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/15/2024 04:15:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/11/2024 08:34:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/01/2024 08:46:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 08:05:35 PM
- Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A • GlobeNewswire Inc. • 09/30/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:13:00 PM
- Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30 • GlobeNewswire Inc. • 09/26/2024 08:01:00 PM
- Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference • GlobeNewswire Inc. • 09/13/2024 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/12/2024 12:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 11:05:40 AM
- Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) • GlobeNewswire Inc. • 09/12/2024 11:00:00 AM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 08/26/2024 08:36:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:45:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:42:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:38:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:36:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:29:45 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/15/2024 08:05:26 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 08/15/2024 10:52:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 10:05:51 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM